Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

The direct targeting of chromatin-associated proteins is increasingly recognized as a
potential therapeutic strategy for the treatment of cancer. In this review, we discuss a …

Aggressive prolactinoma (APRL) is a subgroup of aggressive pituitary tumors (accounting
for 10% of all hypophyseal neoplasia) which are defined by: invasion based on radiological …

Pancreatic neuroendocrine neoplasms (PanNENs) are rare neoplasms arising from islets of
the Langerhans in the pancreas. They can be divided into two groups, based on peptide …

Introduction Until recently no major epidemiological research of primary
hyperparathyroidism (PHPT) has been conducted in the Russian Federation, this led to the …

Multiple endocrine neoplasia type 1 syndrome (MEN1) is a disease caused by mutations in
the MEN1 tumor suppressor gene leading to hyperparathyroidism, pituitary adenomas, and …

Simple Summary Pancreatic neuroendocrine tumors (PanNETs) and lung NETs (LNETs)
have garnered increased attention in recent years due to their diverse clinical manifestations …

Non-endocrine findings in patients with MEN1 (multiple endocrine neoplasia) syndrome
also include skin lesions, especially tumor-type lesions. This is a narrative review of the …

Background Familial primary hyperparathyroidism (PHPT) includes syndromic and non-
syndromic disorders. The former are characterized by the occurrence of PHPT in association …

The escalating prevalence of diabetes mellitus underscores the need for a comprehensive
understanding of pancreatic beta cell function. Interest in glucose effectiveness has …